Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA starts evaluating use of COVID-19 vaccine Comirnaty in children aged 5 to 11 18 October 2021NewsHumanCOVID-19PaediatricsVaccines New manufacturing sites and new formulation approved for COVID-19 vaccine from BioNTech/Pfizer 18 October 2021NewsHumanCOVID-19Vaccines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 October 2021 15 October 2021NewsHumanMedicinesReferrals First-in-class medicine to treat aggressive form of breast cancer 15 October 2021NewsHumanMedicines EMA starts rolling review of Evusheld (tixagevimab and cilgavimab) 14 October 2021NewsHumanCOVID-19Medicines EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by CureVac AG 12 October 2021NewsHumanCOVID-19Vaccines A global approach to regulatory flexibility to increase manufacturing capacity during COVID-19 12 October 2021NewsHumanCOVID-19MedicinesVaccines EMA receives application for marketing authorisation for Ronapreve (casirivimab / imdevimab) for treatment and prevention of COVID-19 11 October 2021NewsHumanCOVID-19Paediatrics Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 5-7 October 2021 8 October 2021NewsVeterinaryMedicines Highlights of Management Board – October 2021 meeting 8 October 2021NewsCorporate 1 … 53 54 55 56 57 Page 57 of 380 58 59 60 61 … 380
EMA starts evaluating use of COVID-19 vaccine Comirnaty in children aged 5 to 11 18 October 2021NewsHumanCOVID-19PaediatricsVaccines
New manufacturing sites and new formulation approved for COVID-19 vaccine from BioNTech/Pfizer 18 October 2021NewsHumanCOVID-19Vaccines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 October 2021 15 October 2021NewsHumanMedicinesReferrals
EMA starts rolling review of Evusheld (tixagevimab and cilgavimab) 14 October 2021NewsHumanCOVID-19Medicines
EMA ends rolling review of CVnCoV COVID-19 vaccine following withdrawal by CureVac AG 12 October 2021NewsHumanCOVID-19Vaccines
A global approach to regulatory flexibility to increase manufacturing capacity during COVID-19 12 October 2021NewsHumanCOVID-19MedicinesVaccines
EMA receives application for marketing authorisation for Ronapreve (casirivimab / imdevimab) for treatment and prevention of COVID-19 11 October 2021NewsHumanCOVID-19Paediatrics
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 5-7 October 2021 8 October 2021NewsVeterinaryMedicines